Financial results for the period ended September 30, 2026
As filed · GPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
EarningsMajormateriality 78 out of 100
What happened
FactFinancial results for the period ended September 30, 2026. 67— GPT Healthcare Limited. Declared Interim Dividend @10% (X 1/- per equity share) for the Financial Year 2026-27 and pursuant.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
RevisedEarlierQ2 FY26
EBITDA stood at Rs. 43 crores, with EBITDA margin of 19%
NowQ2 FY26
PAT stood at Rs. 18.3 crores, PAT margin of 8%
Change
FactTarget revision
Implication
CapitSignal interpretationThe stated figure moved -57.44%.confidence 60%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the (management committed by FY27)
- Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to (management committed by FY27)
Evidence
- GPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q2 FY26
- Latest statement · Q2 FY26
- Earlier statement · Q2 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%